FDA Inspection
Quagen Pharmaceuticals LLCQuagen Pharmaceuticals LLC – FDA Inspection, Dec 19, 2022
Record Details
This FDA Inspection record concerns Quagen Pharmaceuticals LLC, with an inspection on December 19, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Quagen Pharmaceuticals LLC
- Inspection Date
- December 19, 2022
- Product Type
- Drugs
View Company Profile
ID · 3a1b6eac-9184-4d2e-b6aa-a723c03b5fdf
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1194335
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Quagen Pharmaceuticals LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2026 | Not classified | New Jersey District Office | |
| November 8, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 15, 2019 | Not classified | New Jersey District Office |
Other documents for Quagen Pharmaceuticals LLC
- FDA Inspection 1322648 - 2026-05-19
- FDA Inspection 1222389 - 2023-11-08
- FDA Inspection 1085743 - 2019-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.